Pharmafile Logo
Pharmafocus logo
Advanced Search

Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases

March 30, 2023
Business Services

London, UK, March 30, 2023 – Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating …

News
Press release

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

March 30, 2023
Business Services

Netanya, Israel, March 30, 2023 – Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced …

News
Press release

PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM

March 30, 2023
Business Services

Basildon, UK – For immediate release, 27 March 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …

News
Press release

Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards

March 30, 2023
Business Services

  London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …

News
Press release

UK and Polish regulatory authorities approve Akari Therapeutics’ higher-yielding manufacturing process

March 30, 2023
Manufacturing and Production

Akari Therapeutics has announced that the UK’s MHRA and the Polish Office for Registration of Medicinal Products, Medical Devices and …

News

Hovione and Laxxon Medical sign partnership over 3D printed pharmaceutical applications

March 30, 2023
Medical Communications

Hovione, a CDMO, and Laxxon Medical, a pharma-technology company, have signed a strategic partnership deal to bring 3D printing technologies …

News

Janssen reports new Rybrevant data for patients with advanced non-small cell lung cancer

March 30, 2023
Research and Development

Janssen, part of Johnson & Johnson, has announce new long-term data from its CHRYSALIS study, which assessed Rybrevant (amivantamab) in …

News

Alzheimer’s drug Leqembi expected to generate $12.9bn in sales by 2028

March 30, 2023
Sales and Marketing

After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a …

News

Netris Pharma doses first patient in pancreatic cancer study

March 29, 2023
Research and Development

Netris Pharma has announced that it has dosed its first patient in the Lap-NET1 study for the safety and efficacy …

News

AbbVie’s upadacitinib meets primary endpoint in trial for systemic lupus erythematosus

March 29, 2023
Research and Development

AbbVie has shared that upadacitinib (Rinvoq) has been shown to be effective in treating patients with moderately-to-severely-active systemic lupus erythematosus …

News

Genialis raises $13m in Series A funding for the development of AI/ML patient classifiers

March 29, 2023
Medical Communications

Genialis, a computational precision medicine company, has announced that it’s raised more than $13m in Series A funding, co-led by …

News

University of Dundee aids AI research for hypertension

March 29, 2023
Medical Communications

The University of Dundee has announced its involvement in a Europe-wide project which will study whether AI can improve the …

News

Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B

March 28, 2023
Business Services

OXFORD, United Kingdom, March 28, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …

News
Press release

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry

March 28, 2023
Business Services

Milan, Italy, March 28, 2023, 12:30 pm CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …

News
Press release

TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA

March 28, 2023
Business Services

London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) …

News
Press release

Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

March 28, 2023
Business Services

ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that …

News
Press release

iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)

March 28, 2023
Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 28 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …

News
Press release

Sofinnova Partners launches Digital Medicine Strategy

March 28, 2023
Business Services

PARIS, France – March 28, 2023 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in …

News
Press release

Vantage Nutrition LLC acquires ComboCap Inc

March 28, 2023
Business Services

Vantage Nutrition, an ACG group company announces full shareholding ownership of ComboCap Inc (USA) and BioCap (South Africa).  

News
Press release

Eli Lilly invests $1bn in Limerick manufacturing facilities

March 28, 2023
Manufacturing and Production

Pharma company Eli Lilly is increasing its investment in its new manufacturing facilities in Limerick, Republic of Ireland. Today’s announcement …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025